Alain Duflos
9Patents
4h-index
13Co-inventors
54Inventor score
Filing activity: Dec 28, 1990 → Jan 18, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7241444B2 | Anti-IGF-IR antibodies and uses thereof | Emerging Cross-Sectional Technologies | 54 | Expired |
| US5385931A | Sulfonamides derived from benzocyclic or benzoheterocyclic acids, their preparation and application in therapeutics | Chemistry; Metallurgy | 20 | Expired |
| US6127377A | Vinca alkaloid antimitotic halogenated derivatives | Human Necessities | 13 | Expired |
| US7553485B2 | Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof | Chemistry; Metallurgy | 9 | Expired |
| US7914784B2 | Anti-IGF-IR antibodies and uses thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US8101180B2 | Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US8168410B2 | Anti-IGF-IR antibodies and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US5182273A | Spirocyclic N, O derivatives of cyclotriphosphazenes and their use in therapy | Human Necessities | 1 | Expired |
| US8808999B2 | Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.